Artivion, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
AORT
Artivion, INCForm 4: Artivion Executive Sells Shares
Jean F Holloway, SVP, General Counsel of Artivion, Inc., sold 977 shares of common stock on August 12, 2026 for $28.49 per share.
NYSE
AORT
Artivion, INCAndrew M. Green, SVP at Artivion, Inc., executed a series of stock transactions on June 11, 2026, under a pre-established Rule 10b5-1 trading plan.
NYSE
AORT
Artivion, INCDirector Anthony B. Semedo transferred 6,325 shares of Artivion common stock to a living trust for estate planning purposes.
NYSE
AORT
Artivion, INCDirector Marna P. Borgstrom filed an amendment to correct administrative errors regarding a restricted stock award grant date and share count.
NYSE
AORT
Artivion, INCArtivion, Inc. director Anthony B. Semedo was granted 7,576 shares of common stock as part of an equity incentive plan.
NYSE
AORT
Artivion, INCDirector Jon W. Salveson was granted 7,576 shares of Artivion, Inc. common stock as part of an equity incentive plan.
NYSE
AORT
Artivion, INCArtivion, Inc. director Elizabeth A. Hoff was granted 7,576 shares of common stock as part of an equity incentive plan.
NYSE
AORT
Artivion, INCDirector Jeffrey H. Burbank acquired 7,576 shares of Artivion, Inc. common stock via an equity incentive grant.
NYSE
AORT
Artivion, INCDirector James Bullock was granted 7,576 shares of Artivion common stock as part of an equity incentive plan.
NYSE
AORT
Artivion, INCDirector Daniel J. Bevevino was granted 7,576 shares of Artivion, Inc. common stock as part of an equity incentive plan.
NYSE
AORT
Artivion, INCDirector Thomas F. Ackerman was granted 7,576 shares of common stock in Artivion, Inc. as part of an equity incentive plan.
NYSE
AORT
Artivion, INCArtivion, Inc. director Marna P. Borgstrom received a grant of 7,850 restricted stock units as part of the company's annual equity incentive program.
NYSE
AORT
Artivion, INCARTIVION's VP, Chief Accounting Officer, Amy Horton, reported the acquisition of shares from vested performance units and a subsequent sale to cover tax obligations.
NYSE
AORT
Artivion, INCArtivion's SVP, General Counsel, Jean F. Holloway, reported the acquisition of shares from performance stock unit vesting and subsequent sales to cover tax obligations.
NYSE
AORT
Artivion, INCArtivion's SVP, Marshall S. Stanton, reported the vesting of performance stock units and a subsequent 'sell to cover' transaction for tax obligations.
NYSE
AORT
Artivion, INCARTIVION's Chief Commercial Officer, John E. Davis, reported the acquisition of performance stock units and a subsequent sale of shares to cover tax obligations.
NYSE
AORT
Artivion, INCArtivion's EVP, COO, CFO & Treasurer, Lance A. Berry, reported the vesting of performance stock units and a subsequent sale of shares to cover tax obligations.
NYSE
AORT
Artivion, INCARTIVION, Inc. CEO James P. Mackin reported the vesting of performance stock units and a subsequent 'sell to cover' transaction for tax obligations.
NYSE
AORT
Artivion, INCArtivion's VP, Chief Accounting Officer, Amy Horton, sold 641 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.
NYSE
AORT
Artivion, INCArtivion's SVP, Clinical & MD Affair, Marshall S. Stanton, plans to sell 1,513 shares of common stock on March 2, 2026, to cover tax withholding obligations.
NYSE
AORT
Artivion, INCARTIVION, Inc. President & CEO James P. Mackin sold 14,911 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.
NYSE
AORT
Artivion, INCArtivion's SVP, General Counsel, Jean F. Holloway, sold 2,183 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.
NYSE
AORT
Artivion, INCArtivion's EVP, COO, CFO & Treasurer, Lance A. Berry, sold 5,178 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.
NYSE
AORT
Artivion, INCArtivion's Chief Commercial Officer, John E. Davis, sold 2,784 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.
NYSE
AORT
Artivion, INCArtivion's VP, Chief Accounting Officer, Amy Horton, reported sales of common stock to cover tax obligations from vested equity awards and an acquisition of restricted stock.
NYSE
AORT
Artivion, INCArtivion's SVP, Clinical & MD Affair, Marshall S. Stanton, sold shares to cover tax withholding obligations related to vested equity awards.
NYSE
AORT
Artivion, INCArtivion's SVP and General Counsel, Jean F. Holloway, sold shares to cover tax obligations from vested equity and received a new restricted stock grant.
NYSE
AORT
Artivion, INCARTIVION, INC. President & CEO James P. Mackin increased his beneficial ownership by 62,132 shares following a restricted stock grant, despite 'sell to cover' tax transactions.
NYSE
AORT
Artivion, INCArtivion's EVP, COO, CFO & Treasurer, Lance A. Berry, reported sales of common stock to cover tax obligations and an acquisition of restricted stock.
NYSE
AORT
Artivion, INCArtivion's Chief Commercial Officer, John E. Davis, reported sales of shares for tax obligations and a new restricted stock grant.